Literature DB >> 12505990

RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.

Z Buket Yilmaz1, Debra S Weih, Vallabhapurapu Sivakumar, Falk Weih.   

Abstract

Targeted disruption of the Rel/NF-kappaB family members NF-kappaB2, encoding p100/p52, and RelB in mice results in anatomical defects of secondary lymphoid tissues. Here, we report that development of Peyer's patch (PP)-organizing centers is impaired in both NF-kappaB2- and RelB-deficient animals. IL-7-induced expression of lymphotoxin (LT) in intestinal cells, a crucial step in PP development, is not impaired in RelB-deficient embryos. LTbeta receptor (LTbetaR)-deficient mice also lack PPs, and we demonstrate that LTbetaR signaling induces p52-RelB and classical p50-RelA heterodimers, while tumor necrosis factor (TNF) activates only RelA. LTbetaR-induced binding of p52-RelB requires the degradation of the inhibitory p52 precursor, p100, which is mediated by the NF-kappaB-inducing kinase (NIK) and the IkappaB kinase (IKK) complex subunit IKKalpha, but not IKKbeta or IKKgamma. Activation of RelA requires all three IKK subunits, but is independent of NIK. Finally, we show that TNF increases p100 levels, resulting in the specific inhibition of RelB DNA binding via the C-terminus of p100. Our data indicate an important role of p52-RelB heterodimers in lymphoid organ development downstream of LTbetaR, NIK and IKKalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505990      PMCID: PMC140043          DOI: 10.1093/emboj/cdg004

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

Review 1.  Development of Peyer's patches, follicle-associated epithelium and M cell: lessons from immunodeficient and knockout mice.

Authors:  N Debard; F Sierro; J P Kraehenbuhl
Journal:  Semin Immunol       Date:  1999-06       Impact factor: 11.130

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  Compartmentalization of Peyer's patch anlagen before lymphocyte entry.

Authors:  H Hashi; H Yoshida; K Honda; S Fraser; H Kubo; M Awane; A Takabayashi; H Nakano; Y Yamaoka; S Nishikawa
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

5.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

Authors:  G Xiao; E W Harhaj; S C Sun
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

6.  NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.

Authors:  C Smith; E Andreakos; J B Crawley; F M Brennan; M Feldmann; B M Foxwell
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

Authors:  L Yin; L Wu; H Wesche; C D Arthur; J M White; D V Goeddel; R D Schreiber
Journal:  Science       Date:  2001-03-16       Impact factor: 47.728

8.  Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines.

Authors:  D S Weih; Z B Yilmaz; F Weih
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

9.  Inhibition of NF-kappaB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice.

Authors:  S Vallabhapurapu; R P Ryseck; M Malewicz; D S Weih; F Weih
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

10.  Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.

Authors:  A Matsushima; T Kaisho; P D Rennert; H Nakano; K Kurosawa; D Uchida; K Takeda; S Akira; M Matsumoto
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  95 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.

Authors:  Yoshinori Seo; Hidefumi Fukushima; Toshimasa Maruyama; Kayoko Nakao Kuroishi; Kenji Osawa; Kenichi Nagano; Kazuhiro Aoki; Falk Weih; Takahiro Doi; Min Zhang; Keiichi Ohya; Takenobu Katagiri; Ryuji Hosokawa; Eijiro Jimi
Journal:  Mol Endocrinol       Date:  2012-01-26

3.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

4.  Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.

Authors:  Lisa A Madge; Martin S Kluger; Jordan S Orange; Michael J May
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

5.  NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes.

Authors:  Amanda J Fusco; De-Bin Huang; Dustyn Miller; Vivien Ya-Fan Wang; Don Vu; Gourisankar Ghosh
Journal:  EMBO Rep       Date:  2008-12-19       Impact factor: 8.807

Review 6.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

7.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

8.  RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.

Authors:  Jingjing Xu; Peng Zhou; Wenjuan Wang; Aining Sun; Feng Guo
Journal:  J Mol Med (Berl)       Date:  2013-09-17       Impact factor: 4.599

9.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

10.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.

Authors:  Sivakumar Vallabhapurapu; Atsushi Matsuzawa; Weizhou Zhang; Ping-Hui Tseng; Jonathan J Keats; Haopeng Wang; Dario A A Vignali; P Leif Bergsagel; Michael Karin
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.